Baxter Plans Divesting Renal Care Business Into Separate Public Company, Shares Fall

  • Baxter International Inc (NYSE: BAX) announced spinning off its Renal Care and Acute Therapies global business unit into an independent, publicly traded company.

  • The new kidney care company will benefit from its existing product portfolio, diverse footprint, commercial operations, and service capabilities that support its therapies delivered in the home, clinics, and intensive care unit.

  • Related: Baxter Q3 Performance underwhelms Investors, FY22 Guidance Lags Consensus.

  • The business will…

Read More